Well here I am, the moron that Lang referred to. The "bradykinin storm" in no way invalidates the use of RLF 100, if anything it brings into question the use of CCR 5 antagonists. RLF stops the disease process by being a viral entry inhibitor much higher in the course the disease pathway. Yes there could be two mechanisms based on the fairly solid analysis but Dr. Jacobson, but his feeling the "cytokine storm" plays a minor role. Dr. Javitt and Dr. Jacobson have similar background in bio-informational approaches to disease, I wonder if they communicate?

Perhaps using BK inhibitors in conjunction with RLF 100 could be a very potent way to treat. Moreover route of administering (oral and inhaled), and cost effectiveness is very compelling.

I do not believe name calling has any place on public boards.